Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All Videos10 Things That Got Me Through TreatmentCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVCalled to CareEducated Patient Sound BitesExercise of the WeekFrom All AnglesOn Demand: WebinarsShortsText a SurvivorThe Breast Cancer BriefingThe Cancer Search Bar
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gallbladder Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Mesothelioma
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Articles|April 10, 2017

A Roundup of This Week's #CureFacts

Author(s)CURE staff

Did you know that naked mole rats are immune to cancer? Here's a weekly roundup of #CureFact

Advertisement
Advertisement

Related Content

Advertisement
lung cancer

Enhertu Delays Progression in HER2-Mutant Lung Cancer in Phase 3 Trial

ByKaitlyn M. Le
September 14th 2026
blood

3 Trials Advancing Treatment Options for AML and MDS

ByDr. Dina Khalaf
September 14th 2026
lung cancer

Tagrisso Shows 8-Year Survival Benefit in EGFR-Mutated Lung Cancer

ByKaitlyn M. Le
September 14th 2026
Image of Myeloma

New Myeloma Combo Cuts Risk of Relapse by Up to 72% — Here's What It Could Mean for You

ByQuincy Attobrah
September 14th 2026
Image of lungs.

Top 3 Takeaways From WCLC 2026 That Patients Should Know

BySpencer Feldman
September 14th 2026
Advertisement
Advertisement

Trending on CURE

1

Top 3 Takeaways From WCLC 2026 That Patients Should Know

2

5 Years of Lung Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

3

New Myeloma Combo Cuts Risk of Relapse by Up to 72% — Here's What It Could Mean for You

4

Tagrisso Shows 8-Year Survival Benefit in EGFR-Mutated Lung Cancer

5

Enhertu Delays Progression in HER2-Mutant Lung Cancer in Phase 3 Trial

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.